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ABSTRACT
Background Hailey-Hailey disease (HHD) is an autosomal dominant disorder with recur-
rent pruritic vesicles and erosions, and scaly erythematous plaques, particularly involving 
intertriginous areas such as the neck, axillae, groins and perineum. Histopathology shows 
intraepidermal vesiculation with acantholysis in the suprabasal layer. It is caused by 
heterozygous mutations in the ATP2C1 gene, which encodes for the human secretory 
pathway Ca2+/Mn2+ ATPase 1. In this study, we analyze the mutations of the ATP2C1 gene 
in 26 Taiwanese patients with HHD.
Methods In total, 21 familial cases from seven families and 5 sporadic cases (including 
7 previously reported) were retrieved from the medical records. The diagnosis of HHD 
was made based on the characteristic clinical features and histopathological evidence. 
All 27 exons and flanking intron boundaries were amplified by polymerase chain reaction 
and the products were analyzed by direct sequencing.
Results We identified three nonsense mutations (R39X, R468X, R783X), two splice-site 
mutations (483 + 2ta, 832GA), four deletion mutations (nt884-904del, 1459delCTCA, 
1874delA, 1975delA) and one missense mutation (A730T). Two unrelated families with 
nonsense mutation R783X had the comorbidity of chronic schizophrenia since the 
third decade.
Conclusions We report two novel mutations (832GA and 1874delA) of ATP2C1 
involved in HHD. The nonsense mutation R783X might represent a mutational “hotspot” 
in the ATP2C1 gene. The present study demonstrates that a spectrum of ATP2C1 gene 
mutations is present in Taiwanese HHD patients.
Copyright © 2010, Taiwanese Dermatological Association. 
Published by Elsevier Taiwan LLC. All rights reserved.
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Introduction
Familial benign chronic pemphigus or Hailey-Hailey dis-
ease (HHD; OMIM 169600) is an autosomal dominant dis-
order of keratinocyte cohesion,1 characterized by recurrent 
pruritic vesicles, erosions and scaly erythematous plaques, 
particularly involving intertriginous areas such as the neck, 
axillae, groins and perineum. HHD affects both sexes equally 
and usually appears after puberty, mostly in the third or fourth 
decade of life. The disease is characterized by recurrent ex-
acerbations and remissions lasting from months to years.1 
Histologically, there is widespread loss of cohesion between 
keratinocytes with epidermal clefting or vesiculation, giving 
the epidermis the appearance of a “dilapidated brick wall”. 
Ultrastructural studies have revealed perinuclear aggre-
gates of keratin intermediate filaments which resulted from 
breakdown of desmosome-keratin filament complexes.2 
Studies3,4 have revealed that HHD is caused by mutations 
within the ATP2C1 gene encoding for the medial-Golgi 
Ca2+ pump or human secretory pathway Ca2+/Mn2+ ATPase 1 
(hSPCA1). To date, more than 127 mutations have been 
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reported, including nonsense, missense, frameshift and splice-
site mutations.5−12 In this study, we performed mutation 
analysis of the ATP2C1 gene in 26 Taiwanese HHD patients 
(21 familial cases from seven families and 5 sporadic cases).
Methods
Patients
Twenty-six patients (21 familial and 5 sporadic cases) at our 
out-patient clinic were recruited in this study. All patients 
showed recurrent pruritic vesicles and erosions, particu-
larly involving intertriginous areas such as the neck, axillae 
and groins. At least one affected individual from each fam-
ily and all sporadic cases had a skin biopsy for histological 
confirmation. Histology revealed suprabasal cleavage in the 
epidermal cells of the spinous layer, with loss of intercellu-
lar bridges (“dilapidated brick wall” appearance). Moreover, 
any history of other comorbid medical problems, including 
psychiatric disorders, was recorded.
Polymerase chain reaction (PCR) amplification and 
sequence analyses
Genomic DNA was extracted from peripheral blood of the 
patients and nuclear family members. Informed consent was 
obtained from each subject. DNA samples were then sub-
jected to mutation screening by amplification of segments 
of ATP2C1 spanning all 27 exons of the gene using primers 
synthesized on the basis of intronic sequences (Table 1).3,4
For PCR amplification, approximately 200 ng of genomic 
DNA, 12.8 pmol/L of each primer, 10 μmol/L of deoxyribo-
nucleoside triphosphate and 1.25 U of AmpliTaq Gold (Perkin 
Elmer, Roche Molecular Systems, Inc., Branchburg, NJ, 
USA) were used in a total volume of 50 μL. The amplifica-
tion conditions were 94°C for 5 minutes, followed by 35 cy-
cles of 94°C for 45 seconds, annealing temperature (Table 1) 
for 45 seconds and 72°C for 45 seconds, and extension at 
72°C for 10 minutes. The PCR products were examined on 
2% agarose gel. The products were analyzed on an ABI 377 
automatic sequencer (Advanced Biotechnologies, Columbia, 
MD, USA).
Results
Mutation analysis
Results are summarized in Table 2. The affected members 
presented with similar clinical findings. We detected 10 dif-
ferent mutations. Three substitutions resulted in premature 
termination codons (PTCs; R39X, R468X, R783X). Three 
deletion mutations (1459delCTCA, 1874delA [Figure 1], 
Table 1 Polymerase chain reaction primers for amplification of ATP2C1 from genomic DNA.
Exon Forward primer (5 3) Backward primer (5 3) Product size (bp) AT
 1 GAA CTC CTT CCT CAG CCT CT CTT AAA AGC AAA CCA CCA CA 301 50ºC
 2 CTT TCC TAT TAG GAC TAG CT CAG CAC TGT TTT ATA GAG TC 333 50ºC
 3 CTC CCT CTC TAT GTG TCA CT CAA CCT AAC AGT AAG CCC CA 457 50ºC
 4 CAG TCA TGC TCT TAT GGT TT CTG AGA GCA CTT CTC AAT TT 280 50ºC
 5 CTT TTC CAG CTG ATC TCA GT CTA CCA CAA GAC ACC TTG AT 234 50ºC
 6 CAA GCT TTT CTG GGT AAG AA CGG TAC TAG TCA CAT TCA AC 276 50ºC
 7 CTC AGA CAA GCC TAC TGG AA CTC CCA CAG TCC CTA ATA TG 445 50ºC
 8 CAA GAT GTG GCT AAT CAA TG CTC CCC AGT TTC ACA AAT AG 427 50ºC
 9 CAT CTT CAC TGT AGG TAA GA CAG AGA CAA CTG ATT TCC AT 307 50ºC
10 CAA GCA CTT AGC AAG CCC CT CTA GAA TAC CAC CAC CCT TC 236 50ºC
11 CTT CAG CTT GTT CTG TTC CT CGT AAG CTA TGT CCA TTA GA 207 50ºC
12 CTT AAC CTG GCA GCT ACT AG CTC ACC TAA GGG ATA GGA AT 491 50ºC
13 CAG AGA AGT AGG ACA GGA TT GAC ACT GGA ACT GTT AGG AA 282 50ºC
14 + 15 GTC TTG TCA CCA CCA AGT GT GTG AGG GCA GTG TCT CAA AT 384 50ºC
16 CCA GCC AAC CTA GTT ACA AG CTA AAC CCA AAG GTG GAC AG 284 50ºC
17 CTC CAA TGG CAG GTA AGT AC GAA GGC TCT ACC TTT CCA CC 266 50ºC
18 CTG ATG TTT TCA TGA CTC AC CAT GAG TCG ATT TCA ATT GC 238 50ºC
19 CAT TAC GTT GAC TAG CCT GT AGA ATA AGG CCT TTC AGT CC 208 50ºC
20 GCT TGA TCT CAG TGG CAA AT CTT GAT GCT CTA CTC CCT GT 274 50ºC
21 CAT TGA ACA ATG GGT GGT CT CAG TTG AAT TCT CTA GGG GT 265 50ºC
22 CAC AGT GCC CGG TTG GAA AT CAG AAG ACC CAT GGT GAC AA 218 50ºC
23 GTA GAA GGG GTA TTG TGT AG GTG GAA AGG CTC AGA TCT AC 602 50ºC
24 CAG CCA GCG TTT TAT GAT GC CCT TCT GGG TAA CCC ATC AA 377 50ºC
25 CAG CTA TTC ACT AGG TGA TT CAC TCT ACT CAA GTG AGT CA 324 50ºC
26 GAA CTC TCT GCT CTG CCA AC CCT GAG CTT CCC CAA GTG AA 318 50ºC
27 CTG GGT GAC AGA GCA AGA CT CAT TTG GGA CTG CCA GCA GG 445 68ºC
AT = annealing temperature; bp = base pairs.
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1975delA) created shifts in the reading frame and 
resulted in PTCs. SHHD-2 had a 21-bp deletion 
(CCATTGTGGTCACAGTGACGC) at nucleotide 884–904 
position, located in transmembrane domain 4 (M4), result-
ing in missense mutation P295V and deletion of seven 
amino acids from 296 to 302 (IVVTVTL). Two splice-site 
mutations (483 + 2 ta and 832GA) were predicted to 
alter the splicing site of intron 7 and exon 10, respectively. 
One missense mutation (A730T) located in transmembrane 
domain 6 (M6) and at a position conserved with the rat 
SPLA, yeast PMR1 sequences and the human ATP2A2b se-
quence was identified. Two families (FHHD-6 and FHHD-
7) and one sporadic case (SHHD-5) exhibited the same 
nonsense mutation (R783X). None of these mutations was 
detected in the 50 control individuals, indicating that they 
are not likely to be neutral polymorphisms.
Table 2 ATP2C1 mutations in patients with Hailey-Hailey disease (HHD).13
Patients* Location Mutation† Nucleotide change‡ Consequence§
FHHD-1(6)|| Exon 3 R39X 115C  T Nonsense
FHHD-2(3)|| Intron 7 483 + 2t  a TTGAgtaa  TTGAgaaa Splice site
SHHD-1 Exon 10 832G  A 832G  A Splice site
SHHD-2|| Exon 12 nt884 − 904del CCCCATTGTGGTCACAGTGACGCTA  CCTA P295V + del 7 aa
FHHD-3 Exon 16 R468X 1402C  T Nonsense
SHHD-3|| Exon 17 1459delCTCA TACTCAGC  TAGCAGCA Frameshift (PTC + 32 aa)
SHHD-4 Exon 20 1874delA GGCACAAGATG  GGCACAGATGA Frameshift (PTC + 1 aa)
FHHD-4(2)|| Exon 21 1975delA AGACATGA  AGACTGAT Frameshift (M659X)
FHHD-5(6)|| Exon 23 A730T 2188G  A Missense
FHHD-6(2)|| Exon 25 R783X 2347C  T Nonsense
FHHD-7(1) Exon 25 R783X 2347C  T Nonsense
SHHD-5 Exon 25 R783X 2347C  T Nonsense
*Prefix “S” before HHD indicates sporadic cases, whereas prefix “F” indicates familial cases. Number of affected individuals who underwent mutation 
analysis in each family is indicated in parentheses; †numbering of the amino acids to the peptide sequence; ‡numbering of the nucleotides refers to 
ATP2C1 cDNA sequence, with the first nucleotide of ATG initiation codon as 1. Bases in exons are denoted by upper case letters, bases in introns by lower 
case letters, and altered bases are underlined; §”PTC + n aa” indicates that the premature termination codon is n amino acids downstream of the mutation; 
||mutations FHHD-1, FHHD-2, FHHD-4 to FHHD-6, SHHD-2 and SHHD-3 were reported previously.13 aa = amino acids.
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Figure 1 Automated DNA sequencing of ATP2C1 revealed (A) a het-
erozygous deletion mutation in the proband (1874delA, resulting in 
frameshift and premature termination codon + 1 amino acid). (B) Normal 
sequence from control.
Genotype-phenotype comparison
SHHD-2 showed flesh-colored papules over inguinal and 
axillary areas, resembling condyloma acuminatum that re-
quired carbon dioxide laser resurfacing treatment twice. Two 
families (FHHD-6 and FHHD-7) with nonsense mutation 
R783X were reported to have chronic schizophrenia since 
the third decade. However, the sporadic case (SHHD-5) with 
the same mutation did not report any psychiatric problems.
Discussion
HHD, an autosomal dominant disorder that appears to rep-
resent a defect in keratinocyte adhesion, is characterized 
by recurrent eruption of vesicles and bullae involving pre-
dominantly the neck, groins and axillary regions. Genetic 
linkage studies have shown the HHD region to be localized 
to 3q21-q24.14,15 Hu et al3 and Sudbrak et al4 have re-
vealed that HHD is caused by mutations in the ATP2C1 gene 
encoding the medial-Golgi Ca2+ pump or hSPCA1. More than 
127 mutations have been reported to date, including non-
sense, missense, frameshift and splice-site mutations.
In this study, we report 10 mutations in the ATP2C1 gene 
in 26 Taiwanese HHD patients, including 3 nonsense muta-
tions (115CT, R39X; 1402CT, R468X; 2347CT, R783X), 
4 deletion mutations (21-bp deletion mutation [nt884-
904del], 1459delCTCA, 1874delA and 1975delA), 2 splice-
site mutations (483 + 2ta and 832GA), and one missense 
mutation (2188GA, A730T). Two of them (832GA and 
1874delA) are novel and have not been previously reported 
(Table 2). Three nonsense mutations (115CT, 1402CT, 
2347CT) and three deletion mutations (1459delCTCA, 
1874delA and 1975delA) cause a shift in the reading frame 
and result in PTCs (R39X, R468X, R783X, PTC + 32 amino 
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five (50%) are nonsense or frameshift deletions that leads to 
PTCs. Interestingly, in our study, 6 of the 10 mutations, in-
cluding one 21-bp deletion (P295V + del IVVTVTL) and one 
missense mutation (A730T), are also located in membrane 
helices M4, M5 and M6 which are involved in Ca2+/Mn2+ 
binding and the large intervening cytosolic loop that com-
prises the nucleotide-binding and phosphorylation do-
mains. The similarities between these two studies could be 
partly attributed to the similar genetic background shared 
by Hong Kong Chinese and Taiwanese.
Affective disorders have been associated with HHD in the 
early 1990s,22,23 as has Darier’s disease in 2000s.24,25 Recently, 
another report by Yokota and Sawamura26 also revealed such 
an association, where personal and family history of HHD 
and affective disorder was detected with a 4-base deletion, 
1782delAGTC in the ATP2C1 gene. The mutation causes a 
frameshift in the reading frame which results in introduc-
tion of a premature stop codon six amino acids downstream 
of the deletion site. Interestingly, two unrelated familial 
cases (FHHD-6 and FHHD-7) in our study were also found 
to have chronic schizophrenia since the third decade. Both 
of them have nonsense mutation 2347CT (R783X). 
However, another sporadic case (SHHD-5) with the same 
mutation did not have any underlying mental disorders. 
Whether the patient with this mutation has a higher suscep-
tibility to schizophrenia needs to be further elucidated. 
Moreover, in our study, R783X might represent a muta-
tional “hotspot” in the ATP2C1 gene in our patients.
Extracellular calcium plays a critical role in regulating 
differentiation and adhesion of cultured keratinocyte.27,28 
Low levels of Ca2+ induce keratinocyte proliferation, while 
physiological levels of extracellular Ca2+ induce cell-to-cell 
adhesion and keratinocyte differentiation, and control lipid 
secretion and profilaggrin processing29 associated with for-
mation of a cornified layer. The identification of ATP2C1 as 
the gene defect in HHD provided further evidence of the 
critical role of Ca2+ signaling in the normal functioning of 
stratified squamous epithelia.
The mechanism by which ATP2C1 mutations cause 
acantholysis is unknown. Hu et al3 found that HHD kerati-
nocytes displayed higher levels of free cytoplasmic Ca2+ at 
rest compared with normal keratinocytes when cultured in 
medium with either low (0.09 mmol/L) or high (1.2 mmol/L) 
Ca2+ concentrations. In addition, HHD keratinocytes were 
less responsive to increases in extracellular Ca2+ levels. These 
data demonstrate that keratinocytes bearing an ATP2C1 
mutation are deficient in intracellular Ca2+ regulation under 
both resting and stimulated conditions. Elevated cytoplas-
mic calcium might act by altering post-translational modifi-
cation of proteins (for example, through activation of protein 
kinase C, which in turn causes phosphorylation of desmo-
plakin and disruption of desmosome) or by inducing changes 
in gene expression (for example, through activation of ke-
ratinocyte calcineurin).3,30 Alternatively, low Golgi divalent 
acids, PTC + 1 amino acids and M659X, respectively). There 
was a ta change in the consensus sequence at the donor 
end of intron 7 (483 + 2ta, FHHD-2) as well as a GA 
change at the end of exon 10 (832GA, SHHD-1), both of 
which are consistent with splice-site mutations. Consequently, 
ATP2C1 with these mutations will encode abnormal gene 
products of truncated or grossly mutant hSPCA1 proteins.
Peptide sequences behind the splicing mutations could not 
be deduced because skin mRNA samples were not available 
for further study. 
The Ca2+ binding and translocation sites are in the cavity 
between M4, M5 and M6, where they are formed by the pre-
cise juxtaposition of Ca2+ binding residues located in these 
three helices.16 When the sites are mutated in these three 
transmembrane domains, pump activity is blocked at a vari-
ety of different steps in the reaction cycle. One 21-bp deletion 
of the ATP2C1 gene was detected, resulting in P295V and 
deletion of seven amino acids from 296 to 302 (IVVTVTL). 
These amino acids are located within M4.17 Glu-292 has 
been shown to be the putative ion-binding residue in M4 
and the missense mutation G293C cause preferential loss 
of sensitivity to Mn2+.18 Also, a mutation in the putative M4 
Ca2+-binding site of S. cerevisiae was shown to have a more 
deleterious effect on the transportation of Mn2+ in compari-
son to Ca2+.19 Thus, we speculate that the 21-bp deletion 
from nucleotide 884 to 904 might alter the sterical struc-
ture of M4 and compromise the Mn2+ transport capability 
of hSPCA1. Similarly, the missense mutation (A730T) is lo-
cated in M6. A previous study18 has demonstrated that Asp-
726 is equally important for the binding of Ca2+ and Mn2+, 
and the mutation D726Y were devoid of Ca2+- and Mn2+-
dependent phosphoenzyme formation from ATP. Due to its 
location relative to residue Asp-726, missense mutation 
A730T might also have some effect over the Ca2+ and Mn2+ 
transport capability of hSPCA1. The precise consequences 
of these defects on mRNA expression are unknown as RNA 
was not available for our patients.
Six out of the 10 mutations (60%) identified in this study 
are nonsense or frameshift deletions that lead to PTCs. The 
predicted effect of such mutations results in an absence or 
a marked reduction of mutant hSPCA1 protein expression as 
a consequence of either nonsense-mediated mRNA decay20 
or endoplasmic reticulum-associated degradation by the 
cell.21 Nevertheless, the observation that a high proportion 
of the ATP2C1 mutations reported to date lead to PTCs sug-
gests that haploinsufficiency is a prevalent mechanism for 
the dominant inheritance of HHD. The possibility, however, 
that some PTCs may lead to truncated proteins that cause 
disease through a dominant-negative mechanism cannot 
be discounted.
One recent study by Cheng et al11 documents 10 mutations 
that cause Hailey-Hailey disease in Hong Kong Chinese; 
these include two nonsense, three deletion, one insertion, 
two splice-site and two missense mutations. Among them, 
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12. Tian H, Yan X, Liu H, et al. Six novel ATP2C1 mutations identified 
in Chinese patients with Hailey-Hailey disease. J Dermatol Sci 
2010;58:80–2.
13. Chao SC, Tsai YM, Yang MH. Mutation analysis of ATP2C1 gene 
in Taiwanese patients with Hailey-Hailey disease. Br J Dermatol 
2002;146:595–600.
14. Ikeda S, Welsh EA, Peluso AM, et al. Localization of the gene 
whose mutations underlie Hailey-Hailey disease to chromosome 
3q. Hum Mol Genet 1994;3:1147–50.
15. Richard G, Korge BP, Wright AR, et al. Hailey-Hailey disease maps 
to a 5 cM interval on chromosome 3q21-q24. J Invest Dermatol 
1995;105:357–60.
16. MacLennan DH, Rice WJ, Green NM. The mechanism of Ca2+ 
transport by sarco(endo)plasmic reticulum Ca2+-ATPases. J Biol 
Chem 1997;272:28815–8.
17. MacLennan DH, Brandl CJ, Korczak B, Green NM. Amino-acid 
sequence of a Ca2++ Mg2+-dependent ATPase from rabbit mus-
cle sarcoplasmic reticulum, deduced from its complementary 
DNA sequence. Nature 1985;316:696–700.
18. Fairclough RJ, Dode L, Vanoevelen J, et al. Effect of Hailey-
Hailey Disease mutations on the function of a new variant of 
human secretory pathway Ca2+/Mn2+-ATPase (hSPCA1). J Biol 
Chem 2003;278:24721–30.
19. Wei Y, Chen J, Rosas G, et al. Phenotypic screening of mutations 
in Pmr1, the yeast secretory pathway Ca2+/Mn2+-ATPase, reveals 
residues critical for ion selectivity and transport. J Biol Chem 
2000;275:23927–32.
20. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in 
health and disease. Hum Mol Genet 1999;8:1893–900.
21. Hampton RY. ER-associated degradation in protein quality control 
and cellular regulation. Curr Opin Cell Biol 2002;14:476–82.
22. Korner J, Rietschel M, Nothen MM, et al. Familial cosegregation 
of affective disorder and Hailey-Hailey disease. Br J Psychiatry 
1993;163:109–10.
23. Wilk M, Rietschel M, Korner J, et al. Pemphigus chronicus benignus 
familiaris (Hailey-Hailey disease) and bipolar affective disease in 
3 members of a family. Hautarzt 1994;45:313–7. [In German]
24. Mei S, Amato L, Gallerani I, et al. A case of vesiculo-bullous 
Darier’s disease associated with bipolar psychiatric disorder. 
J Dermatol 2000;27:673–6.
25. Wang SL, Yang SF, Chen CC, et al. Darier’s disease associated with 
bipolar affective disorder: a case report. Kaohsiung J Med Sci 
2002;18:622–6.
26. Yokota K, Sawamura D. Hailey-Hailey disease with affective 
disorder: report of a case with novel ATP2C1 gene mutation. 
J Dermatol Sci 2006;43:150–1.
27. Hennings H, Holbrook KA. Calcium regulation of cell-cell con-
tact and differentiation of epidermal cells in culture. An ultrastruc-
tural study. Exp Cell Res 1983;143:127–42.
28. Watt FM, Mattey DL, Garrod DR. Calcium-induced reorganiza-
tion of desmosomal components in cultured human keratinoc-
ytes. J Cell Biol 1984;99:2211–5.
29. Resing KA, al-Alawi N, Blomquist C, et al. Independent regulation 
of two cytoplasmic processing stages of the intermediate filament-
associated protein filaggrin and role of Ca2+ in the second stage. 
J Biol Chem 1993;268:25139–45.
30. Dobson-Stone C, Fairclough R, Dunne E, et al. Hailey-Hailey 
disease: molecular and clinical characterization of novel mutations 
in the ATP2C1 gene. J Invest Dermatol 2002;118:338–43.
cation (Ca2+ or Mn2+) concentration might impair post-
translational modification (proteolytic processing and glyc-
osylation) of proteins important in cell-cell adhesion, leading 
to acantholytic characteristic of HHD.3,30
In conclusion, we report the mutation analysis of ATP2C1 
involved in HHD in Taiwanese. The nonsense mutation R783X 
might represent a mutational “hotspot” in the ATP2C1 gene. 
This study demonstrates that a spectrum of ATP2C1 gene 
mutations is present in Taiwanese HHD patients.
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